Skip to Content
Merck
CN

BP1075

Mesalazine

British Pharmacopoeia (BP) Reference Standard

Synonym(s):

5-Aminosalicylic acid, 5-AS, 5-Amino-2-hydroxybenzoic acid, Mesalamine

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
H2NC6H3-2-(OH)CO2H
CAS Number:
Molecular Weight:
153.14
NACRES:
NA.24
UNSPSC Code:
41116107
Beilstein/REAXYS Number:
2090421
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Mesalazine, British Pharmacopoeia (BP) Reference Standard

SMILES string

Nc1ccc(O)c(c1)C(O)=O

InChI key

KBOPZPXVLCULAV-UHFFFAOYSA-N

InChI

1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)

grade

pharmaceutical primary standard

API family

mesalazine, mesalamine

form

powder

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

mp

275-280 °C (dec.) (lit.)

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

Gene Information

Looking for similar products? Visit Product Comparison Guide

Application

5-Aminosalicylic acid is a peroxidase substrate suitable for use in ELISA procedures. This substrate produces a soluble end product that is brown in color and can be read spectrophotometrically at 450 nm. The reaction may be stopped with 3 N NaOH and read at 550 nm.
Mesalazine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Mesalazine Suppositories
  • Mesalazine Foam Enema
  • Mesalazine Enema
  • Mesalazine Prolonged-release Tablets
  • Mesalazine Gastro-resistant Tablets
  • Mesalazine Prolonged-release Granules
  • General description

    This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

    Other Notes

    Sales restrictions may apply.
    Learn how British Pharmacopoeia (BP) sets the standard by offering quality British Pharmacopoeia Chemical Reference Substances (BPCRS).

    Packaging

    Unit quantity: 125 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    pictograms

    Exclamation mark

    signalword

    Warning

    Hazard Classifications

    Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

    target_organs

    Respiratory system

    Storage Class

    11 - Combustible Solids

    wgk

    WGK 2

    flash_point_f

    536.0 °F

    flash_point_c

    280 °C


    Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    If you need assistance, please contact Customer Support

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Jingyi Hu et al.
    Journal of ethnopharmacology, 266, 113394-113394 (2020-09-18)
    Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disease of the gastrointestinal tract, consisting of ulcerative colitis (UC) and Crohn's disease (CD). Gut microbiota and their metabolites may play a role in the pathogen of IBD, especially of

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service